Understanding Scleroderma Trial Participation
Part of Skin clinical trials.
This study looks at what influences people with scleroderma to join clinical trials. By taking part, you help researchers understand how to make future studies more accessible and patient-friendly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with scleroderma
- You plan to join an observational (non-treatment) study
- You are at least 18 years old
- You are not pregnant
- You can complete regular online check-ins
- You can understand and return a signed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a registry of people with scleroderma and may store medical information and samples for future research. It can help researchers better understand the disease and develop better treatments.
This trial collects skin samples from people with scleroderma and from healthy volunteers undergoing plastic surgery. Researchers will study the genes in skin cells to better understand the disease.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This trial tests different ways of sharing research results with people who have scleroderma (a condition that causes hardening of the skin and sometimes internal organs). It aims to find the best way to make study results clear and helpful for patients.
This trial tests new treatments for people with scleroderma-related lung disease. You may be eligible if you have systemic sclerosis with lung scarring, your symptoms started within the last 7 years, and you have not had certain prior treatments or transplants.
Hear when a new Scleroderma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.